Topical application of UV-irradiated Vitamin D on implant surface during implantation for the evaluation of Osteoprotegerin (OPG) and implant stability: A Randomized control study
Not Applicable
- Conditions
- Health Condition 1: K068- Other specified disorders of gingiva and edentulous alveolar ridge
- Registration Number
- CTRI/2024/02/063034
- Lead Sponsor
- King georges medical university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients with edentulous space in the
maxillary jaw having healed bone site
indicated for rehabilitation with
implants.
2.Patient having sufficient residual bone
volume for implant placement.
3.Patient having good general health with no
systemic disease.
4.Patient having adequate oral hygiene.
5.Good general and periodontal health.
Exclusion Criteria
1.Patients who consume alcohol, smoke or use illicit drugs.
2.Patient with any systemic disease, irradiated patients, patients with previous or active treatments with steroids or bisphosphonates
3.Pregnant/lactating women
4.Systemic diseases which can affect bone metabolism such as osteoporosis and endocrine diseases
5. Patients taking antibiotics/steroids/anti inflammatory for the past 3 months.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method osteoprotegerin biomarker <br/ ><br> <br/ ><br>Timepoint: <br/ ><br>0 weeks, 2 weeks, 12 weeks <br/ ><br>
- Secondary Outcome Measures
Name Time Method implant stability <br/ ><br>crestal bone lossTimepoint: 0 weeks, 2 weeks, 12 weeks, 6 months